This is a preview of subscription content, log in via an institution to check access.
Reference
Marquez-Rodas I, et al. Exclusion criteria vs reality: Dual BRAF/MEK inhibition and radiotherapy in a patient with melanoma metastatic to the brain and ECOG 3. Tumori 102 (Suppl. 2): S54-S56, Nov 2016. Available from: URL: http://doi.org/10.5301/tj.5000408 - Spain
Rights and permissions
About this article
Cite this article
Dabrafenib/trametinib. Reactions Weekly 1635, 103 (2017). https://doi.org/10.1007/s40278-017-25352-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-25352-3